Kinarus Therapeutics
Kinarus Therapeutics is a clinical-stage company developing therapies for viral, respiratory and ocular diseases.
5 employees · est. 2017 · Basel, Switzerland
Molecure is the older company (2017 vs 2012); Molecure is the larger of the two.
Side-by-Side Comparison
| Metric | Kinarus Therapeutics | Molecure |
|---|---|---|
| Founded | ||
| Founded | 2017 | 2012 older |
| Headquarters | ||
| Headquarters | Basel, Switzerland | Warsaw, Poland |
| Employees | ||
| Employees | 5 | 85 larger |
| Industry | ||
| Industry | Biopharma, Biotechnology, Health Care | Biopharma, Biotechnology, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Post Ipo Equity | Post Ipo Secondary |
| Total Funding | ||
| Total Funding | $36.55M | $50.00M |
| Funding Rounds | ||
| Funding Rounds | 6 | 1 |
| Services | ||
| Services | Not tracked yet | Not tracked yet |
| Target Customers | ||
| Target Customers | Not tracked yet | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Clinical-stage Pharmaceutical Company, Drug Development, Viral Diseases, Respiratory Diseases, Ophthalmic Diseases, P38 MAPK Inhibitor, Covid-19 Treatment, Phase 2 Clinical Trial, Age-Related Macular Degeneration, VEGF Inhibitors, Regulatory Approval, Patient-focused Treatments, Switzerland-based Company, Roche Collaboration, Hospitalized Patients | Biopharmaceutical, Clinical Stage, Small Molecule Drug Discovery, Immunotherapy, Medicinal Chemistry, Respiratory Diseases, Inflammatory Diseases, Fibrotic Diseases, Chitinase Inhibitor, Arginase Inhibitor, Cancer Treatment, Phase I Clinical Trial, Phase II Clinical Trial, Public Research Partnerships, Listed On Stock Exchange |
| Website | ||
| Website | kinarus.com | molecure.com |
About Kinarus Therapeutics
Kinarus Therapeutics is a clinical-stage pharmaceutical company based in Switzerland. Established in 2017, the company is dedicated to developing innovative treatments for viral, respiratory, and ophthalmic diseases. Their flagship drug candidate is an oral combination of a P38 mitogen-activated pro...
About Molecure
Molecure is a clinical stage biopharmaceutical company based in Poland. Since its establishment in 2012, the company has been dedicated to utilizing its world-leading medicinal chemistry capabilities to address unmet medical needs. Molecure's approach involves discovering and developing first-in-cla...
We will tell you when either one moves
BounceWatch watches Kinarus Therapeutics and Molecure for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Kinarus Therapeutics and Molecure — by email.
Frequently Asked Questions
Compare Kinarus Therapeutics with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Kinarus Therapeutics on 12 Sep 2024, and Molecure on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.